When cancers evolve to the late stage of metastasis they are robust and equipped with genetic, or epigenetic, tricks that can thwart most cancer drugs.11 Given mutation rates, often enhanced by genetic instability, and the number of cells spawned—1012 or more—it is inevitable that rare cells will exist that are intrinsically drug resistant.
No comments:
Post a Comment